Clinical Trial Update: MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is testing an mRNA neoantigen vaccine for non-small cell lung cancer, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MRNA Neoantigen Vaccine

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: NSCLC | EARLY_Phase 1 | Status: NOT_YET_RECRUITING